Stability of PEth 16:0/18:1, 16:0/18:2, 16:0/20:4, 18:0/18:1, 18:0/18:2, and 18:1/18:1 in authentic whole blood samples (at room temperature).
Phosphatidylethanol
alcohol biomarker
dried blood spots
preanalytical handling
stability
Journal
Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449
Informations de publication
Date de publication:
13 Aug 2023
13 Aug 2023
Historique:
revised:
18
07
2023
received:
14
04
2023
accepted:
20
07
2023
medline:
14
8
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
aheadofprint
Résumé
Phosphatidylethanol (PEth) is a direct alcohol biomarker to monitor individuals' drinking behavior that has gained recognition in clinical and forensic settings. The increasing application of the marker makes investigation of the preanalytical handling necessary, and analyte stability deserves major attention. This study was conducted to investigate the change of six PEth homologues' concentration, stored in authentic samples of EDTA blood over a course of 30 days at room temperature (n = 62). The stability criterion of concentration being ±15% of the original concentration was fulfilled at mean for 10, 3, 2, 5, 2, and 7 days for PEth 16:0/18:1, 16:0/18:2, 16:0/20:4, 18:0/18:1, 18:0/18:2, and 18:1/18:1, respectively. Regarding all homologues, there were samples in which concentration had declined by >15% or by more than the critical difference on day 1. Overall, calculated concentration declines were very inhomogeneous, with inter-sample differences of 43%-73% after 30 days. PEth 16:0/18:2, 16:0/20:4, and 18:0/18:2 declined to a greater extent than PEth 16:0/18:1. Blood alcohol concentration was measured >0.1‰ in 25 samples. Three of the six samples that exceeded 115% of initial concentrations were positive for blood alcohol. The study results add to the previously reported information on PEth stability and firstly look at six homologues in comparison. Due to the high scatter of stability among the samples and the observed poor stabilities in some, it can be concluded that transportation and storage times, especially if cooling cannot be provided, must be kept short. If analyzing from dried blood, spotting should preferably be conducted at the site of sampling.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.
Références
Dasgupta A. Alcohol biomarkers-an overview. In: Alcohol and Its Biomarkers: Clinical Aspects and Laboratory Determination. 1st ed. Elsevier; 2015. doi:10.1016/B978-0-12-800339-8.00001-8
Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C. Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Drug Test Anal. 2006;41(4):431-437. doi:10.1093/alcalc/agl027
Gnann H, Weinmann W, Thierauf A. Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Drug Test Anal. 2012;36(9):1507-1511. doi:10.1111/j.1530-0277.2012.01768.x
Gustavsson L, Alling C. Formation of phosphatidylethanol in rat brain by phospholipase D. Drug Test Anal. 1987;142(3):958-963. doi:10.1016/0006-291X(87)91507-5
Gnann H, Engelmann C, Skopp G, et al. Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS/MS. Drug Test Anal. 2010;396(7):2415-2423. doi:10.1007/s00216-010-3458-5
Helander A, Zheng Y. Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Drug Test Anal. 2009;1(6):279-285. doi:10.1002/dta.48
Nalesso A, Viel G, Cecchetto G, Frison G, Ferrara SD. Analysis of the alcohol biomarker phosphatidylethanol by NACE with on-line ESI-MS. Drug Test Anal. 2010;2(10):460-468. doi:10.1002/dta.167
Aboutara N, Szewczyk A, Jungen H, et al. Phosphatidylethanol in patients with liver diseases of different etiologies: analysis of six homologues and comparison with other alcohol markers. Drug Test Anal. 2021;13(10):1783-1790. doi:10.1002/dta.3135
Helander A, Böttcher M, Dahmen N, Beck O. Elimination characteristics of the alcohol biomarker phosphatidylethanol (PEth) in blood during alcohol detoxification. Drug Test Anal. 2019;11(7):1094-1108. doi:10.1002/dta.2584
Arnts J, Vanlerberghe BTK, Roozen S, et al. Diagnostic accuracy of biomarkers of alcohol use in patients with liver disease: a systematic review. Drug Test Anal. 2021;13(9):1603-1613. doi:10.1002/dta.3106
Nowatzke W, Woolf E. Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples. AAPS j. 2007;9(2):E117-E122. doi:10.1208/aapsj0902013
Stamm D. A new concept for quality control of clinical laboratory investigations in the light of clinical requirements and based on reference method values. J Clin Chem Clin Biochem. 1982;20(11):817-824. doi:10.1515/cclm.1982.20.11.817
Skråstad RB, Spigset O, Aamo TO, Andreassen TN. Stability of phosphatidylethanol 16:0/18:1 in freshly drawn, authentic samples from healthy volunteers. J Anal Toxicol. 2021;45(4):417-421. doi:10.1093/jat/bkaa082
Dumitrascu C, van de Lavoir MCA, Neels H, et al. Stability of phosphatidylethanol 16:0/18:1 in authentic and spiked whole blood. Drug Test Anal. 2021;13(6):1219-1222. doi:10.1002/dta.2995
Faller A, Richter B, Kluge M, Koenig P, Seitz HK, Skopp G. Stability of phosphatidylethanol species in spiked and authentic whole blood and matching dried blood spots. Z Rechtsmed. 2013;127(3):603-610. doi:10.1007/s00414-012-0799-y
Wang H, Zhang Y, Zhang X, et al. An LC-MS/MS method for comparing the stability of ethanol's non-oxidative metabolites in dried blood spots during 90 days. Alcohol. 2020;83:29-35. doi:10.1016/j.alcohol.2019.05.007
Bakhireva LN, Shrestha S, Gutierrez HL, Berry M, Schmitt C, Sarangarm D. Stability of phosphatidylethanol in dry blood spot cards. Alcohol Alcohol. 2016;51(3):275-280. doi:10.1093/alcalc/agv120
Aboutara N, Müller A, Jungen H, et al. Investigating the use of PEth, CDT and MCV to evaluate alcohol consumption in a cohort of homeless individuals- a comparison of different alcohol biomarkers. Forensic Sci Int. 2022;331:111147. doi:10.1016/j.forsciint.2021.111147
Aboutara N, Jungen H, Szewczyk A, Sterneck M, Müller A, Iwersen-Bergmann S. Analysis of six different homologues of phosphatidylethanol from dried blood spots using liquid chromatography-tandem mass spectrometry. Drug Test Anal. 2021;13(1):140-147. doi:10.1002/dta.2910
Peters FT. Stability of analytes in biosamples - an important issue in clinical and forensic toxicology? Anal Bioanal Chem. 2007;388(6):1327-1330. doi:10.1007/s00216-007-1267
Schröck A, Henzi A, Bütikofer P, König S, Weinmann W. Determination of the formation rate of phosphatidylethanol by phospholipase D (PLD) in blood and test of two selective PLD inhibitors. Alcohol. 2018;73:1-7. doi:10.1016/j.alcohol.2018.03.003
Beck O, Mellring M, Löwbeer C, Seferaj S, Helander A. Measurement of the alcohol biomarker phosphatidylethanol (PEth) in dried blood spots and venous blood-importance of inhibition of post-sampling formation from ethanol. Anal Bioanal Chem. 2021;413(22):5601-5606. doi:10.1007/s00216-021-03211-z
Jones GRD. Critical difference calculations revised: inclusion of variation in standard deviation with analyte concentration. Ann Clin Biochem. 2009;46(6):517-519. doi:10.1258/acb.2009.009083